Examination Report |
1 | TM-1 | 07 Mar 2014 |
10 | TM-R(RENEWAL OF TRADE MARK) | 17 Oct 2023 |
11 | TM-M(CERTIFICATIE OF REGISTER (U/S 137) / CERTIFIED COPY OF A DOCUMENT) | 12 Dec 2023 |
2 | Authorization Document (POA) | 27 Nov 2014 |
2 | TM-16 | 27 Nov 2014 |
3 | Authorization Document (POA) | 27 Nov 2014 |
3 | TM-16 | 27 Nov 2014 |
4 | TM-16 | 20 May 2015 |
5 | Reply to Exam Report (MIS-R) | 12 Aug 2015 |
6 | Certificate | 12 Aug 2016 |
7 | TM-46 | 30 Sep 2016 |
8 | Journal Copy | 12 Feb 2018 |
9 | TM-M(CERTIFICATIE OF REGISTER (U/S 137) / CERTIFIED COPY OF A DOCUMENT) | 30 Nov 2020 |
1 | RENEWAL INTIMATION LETTER | 16322771 | 21 Oct 2023 |
Trademark was applied on 07 March 2014 with IP India.
Proprietor of Infimab is SUN PHARMACEUTICAL INDUSTRIES.
Class(es) in which the trademark was applied to is 5.
Status of Infimab is Registered.
Application number alloted to the trademark is 2694127.
Trademark has been filed in the following category:
WORD